{"id":1557,"date":"2026-11-16T20:48:45","date_gmt":"2026-11-16T20:48:45","guid":{"rendered":"https:\/\/admit-therapeutics.com\/?p=1557"},"modified":"2026-11-16T20:53:47","modified_gmt":"2026-11-16T20:53:47","slug":"our-company-presents-the-map-ad-prognostic-test-at-rasen-2026","status":"publish","type":"post","link":"https:\/\/admit-therapeutics.com\/en\/our-company-presents-the-map-ad-prognostic-test-at-rasen-2026\/","title":{"rendered":"Our company presents the MAP-AD\u00ae prognostic test at RASEN 2026"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Barcelona (Spain), November 17, 2026. We are currently participating in&nbsp;<strong>RASEN26<\/strong> in Sevilla (Barcel\u00f3 Convention Center), a benchmark event for the advancement of neurology and clinical innovation. Throughout the congress, our team is welcoming attendees at our booth located in the&nbsp;<strong>Polo Tecnol\u00f3gico<\/strong>&nbsp;to showcase the capabilities of the&nbsp;<strong>MAP-AD\u00ae<\/strong>&nbsp;test.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>MAP-AD\u00ae<\/strong> is a <strong>CE-IVDR <\/strong>marked prognostic blood tool designed to predict the progression from Mild Cognitive Impairment (MCI) to Alzheimer&#8217;s dementia. By integrating the analysis of novel mitochondrial epigenetic biomarkers with patient clinical data using a machine-learning approach, this test allows clinicians to anticipate the evolution of the disease and supports early medical decision-making.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Pitch Session at the \u00c1gora<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In addition to our exhibition space, we are part of the official presentation program. We invite you to join our session at the \u00c1gora del Polo Tecnol\u00f3gico to delve into the clinical impact of our technology and its value proposition.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Booth:&nbsp;<\/strong>Polo Tecnol\u00f3gico<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Pitch Session:&nbsp;<\/strong>November 18, 2026, 18:00 h | \u00c1gora del Polo Tecnol\u00f3gico<\/p>\n\n\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Barcelona (Spain), November 17, 2026. We are currently participating in&nbsp;RASEN26 in Sevilla (Barcel\u00f3 Convention Center), a benchmark event for the advancement of neurology and clinical innovation. Throughout the congress, our team is welcoming attendees at our booth located in the&nbsp;Polo Tecnol\u00f3gico&nbsp;to showcase the capabilities of the&nbsp;MAP-AD\u00ae&nbsp;test. MAP-AD\u00ae is a CE-IVDR marked prognostic blood tool designed [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1557","post","type-post","status-publish","format-standard","hentry","category-sin-categorizar"],"acf":[],"_links":{"self":[{"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/posts\/1557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/comments?post=1557"}],"version-history":[{"count":5,"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/posts\/1557\/revisions"}],"predecessor-version":[{"id":1564,"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/posts\/1557\/revisions\/1564"}],"wp:attachment":[{"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/media?parent=1557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/categories?post=1557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/tags?post=1557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}